Medical treatment of benign prostatic hyperplasia and instrumental alternatives

被引:0
|
作者
d'Urologie, Service [1 ]
机构
[1] Hop St Louis, Serv Urol, 1 Ave Claude Vellefaux, F-75084 Paris, France
来源
E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE | 2005年 / 4卷 / 01期
关键词
Benign prostatic hyperplasia; medical therapy; TUNA (transurethral needle ablation);
D O I
10.14607/emem.2005.1.04
中图分类号
R61 [外科手术学];
学科分类号
摘要
Clinical symptoms related to benign prostatic hyperplasia (BPH) combine obstructive and irritative symptoms. Obstructive symptoms, associating at different levels hesitancy, straining, weak flow and interrupted voiding, are related to the outflow obstruction due to the prostate itself through its mass and its tonus, while irritative symptoms, mainly diurnal and nocturnal frequency and urgency, are mostly due to detrusor abnormality, and to some extent to central nervous system disturbance. Prostatic outflow obstruction may be treated by alphablockers which reduce prostatic and bladder neck muscle tone, or by 5 alphareductase inhibitors which reduce glandular volume. Irritative symptoms may be treated by anti-muscarinic agents and at a lower degree by alphablockers. Plant extracts, which mechanism of action remains unclear, namely serenoa repens and pygeum africanum, are widely used in France. The place of instrumental alternatives remains to be determined but these instrumental treatments can now be regarded as possible alternatives to long life medical treatment rather than alternatives to a standard surgical treatment.
引用
收藏
页码:4 / 7
页数:4
相关论文
共 50 条
  • [1] Conservative non-instrumental treatment of benign prostatic hyperplasia
    Bosch, JLHR
    UROLOGICAL RESEARCH, 1997, 25 : S107 - S114
  • [2] Conservative non-instrumental treatment of benign prostatic hyperplasia
    J. L. H. Ruud Bosch
    Urological Research, 1997, 25 : S107 - S114
  • [3] Surgical and instrumental management of benign prostatic hyperplasia
    Muschter, R.
    Reich, O.
    UROLOGE, 2008, 47 (02): : 155 - +
  • [4] Medicoeconomic aspects of benign prostatic hyperplasia medical treatment
    Lebdai, S.
    Azzouzi, A. R.
    Delongchamps, N. -B.
    Benchikh, A.
    Campeggi, A.
    Cornu, J. -N.
    Dumonceau, O.
    Faix, A.
    Fourmarier, M.
    Haillot, O.
    Lukacs, B.
    Mathieu, R.
    Misrai, V.
    Robert, G.
    de La Taille, A.
    Descazeaud, A.
    PROGRES EN UROLOGIE, 2016, 26 (02): : 129 - 136
  • [5] Recent progress in the medical treatment of benign prostatic hyperplasia
    Cornu, Jean-Nicolas
    Roupret, Morgan
    PROGRES EN UROLOGIE, 2007, 17 (05): : 1029 - 1032
  • [6] Recent trials for medical treatment of benign prostatic hyperplasia
    Bernier, PA
    Roehrborn, CG
    INFECTIONS IN UROLOGY, 1997, 10 (04): : 118 - 125
  • [7] Medical Advancements in Benign Prostatic Hyperplasia Treatments
    Ganesan, Vishnuvardhan
    Agarwal, Deepak
    CURRENT UROLOGY REPORTS, 2024, 25 (05) : 93 - 98
  • [8] Medical Advancements in Benign Prostatic Hyperplasia Treatments
    Vishnuvardhan Ganesan
    Deepak Agarwal
    Current Urology Reports, 2024, 25 : 93 - 98
  • [9] Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia
    Harkaway, R. C.
    Issa, M. M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 204 - 214
  • [10] Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia
    R C Harkaway
    M M Issa
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 204 - 214